Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amalia A Van Everdingen

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Arthritis and Rheumatism|April 29, 2006
Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placeboJohannes W G Jacobs, Amalia A van Everdingen, Suzan M M Verstappen, et al.
Arthritis and Rheumatism|April 13, 2004
The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapiesAmalia A van Everdingen, Dirk R Siewertsz van Reesema, Johannes W G Jacobs, et al.
Annals of Internal Medicine|January 5, 2002
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trialAmalia A van Everdingen, Johannes W G Jacobs, Dirk R Siewertsz Van Reesema, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Are glucocorticoids DMARDs?Johannes W J Bijlsma, Jos N Hoes, Amalia A Van Everdingen, et al.
Annals of the New York Academy of Sciences|July 13, 2002
Glucocorticoids in rheumatoid arthritis: effects on erosions and boneJohannes W J Bijlsma, Amalia A Van Everdingen, Margriet Huisman, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Arthritis and Rheumatism|April 29, 2006
Followup radiographic data on patients with rheumatoid arthritis who participated in a two-year trial of prednisone therapy or placeboJohannes W G Jacobs, Amalia A van Everdingen, Suzan M M Verstappen, et al.
Arthritis and Rheumatism|April 13, 2004
The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapiesAmalia A van Everdingen, Dirk R Siewertsz van Reesema, Johannes W G Jacobs, et al.
Annals of Internal Medicine|January 5, 2002
Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trialAmalia A van Everdingen, Johannes W G Jacobs, Dirk R Siewertsz Van Reesema, et al.
Annals of the New York Academy of Sciences|July 21, 2006
Are glucocorticoids DMARDs?Johannes W J Bijlsma, Jos N Hoes, Amalia A Van Everdingen, et al.
Annals of the New York Academy of Sciences|July 13, 2002
Glucocorticoids in rheumatoid arthritis: effects on erosions and boneJohannes W J Bijlsma, Amalia A Van Everdingen, Margriet Huisman, et al.
Pageof 1